Business Description

Description
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.
Name Current Vs Industry Vs History
Equity-to-Asset 0.98
Debt-to-Equity 0.02
Debt-to-EBITDA N/A
N/A
N/A
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Beneish M-Score 0.22
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year FCF Growth Rate -8.3
3-Year Book Growth Rate 22.1
Name Current Vs Industry Vs History
5-Day RSI 45.95
9-Day RSI 57.02
14-Day RSI 59.44
6-1 Month Momentum % 1.22
12-1 Month Momentum % -22.61

Liquidity Ratio

Name Current Vs Industry Vs History

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -6
Shareholder Yield % -7.05